Explore

Slice the corpus on any axis.

Filter by firm, year, function, metric or slide category — then see the result as a narrative arc, a treemap of slide types, or a catalog of slides.

clear
51,416 slides across 1229 decks match.
Making green the mainstream
Accenture · 2024 · context
Making green the mainstream
Reinventing green innovation
Accenture · 2024 · framework_other
Reinventing green innovation
16% — Share of companies pursuing eco-essential innovation
Practical considerations to help your business make a start
Accenture · 2024 · implementation_plan
Practical considerations to help your business make a start
About the research
Accenture · 2024 · appendix
About the research
25,000 — Consumers surveyed
About the authors
Accenture · 2024 · team_bio
About the authors
Acknowledgements / References
Accenture · 2024 · appendix
Acknowledgements / References
About Accenture
Accenture · 2024 · disclaimer
About Accenture
743,000 — Accenture employees
Refueling the innovation engine in vaccines
McKinsey · 2016 · cover
Refueling the innovation engine in vaccines
Initial thoughts on potential solutions
McKinsey · 2016 · strategic_options
Initial thoughts on potential solutions
Questions for discussion
McKinsey · 2016 · next_steps
Questions for discussion
Top 10 infectious diseases by global incidence
McKinsey · 2016 · data_table
Top 10 infectious diseases by global incidence
146,864 — Global incidence
High and Low Endemic Diseases
McKinsey · 2016 · data_table
High and Low Endemic Diseases
100,000 — Incidence
Number of vaccines in development globally (phase I to pre-registration), 2005-15
McKinsey · 2016 · data_table
Number of vaccines in development globally (phase I to pre-registration), 2005-15
266 — Number of vaccines in development
Share of candidates in each stage of development 2005-15
McKinsey · 2016 · data_table
Share of candidates in each stage of development 2005-15
Global vaccine sales, 1996-2020
McKinsey · 2016 · data_table
Global vaccine sales, 1996-2020
39-48 — Global vaccine sales
Global vaccine sales, 1996-2015
McKinsey · 2016 · data_table
Global vaccine sales, 1996-2015
Number of vaccine development programs globally
McKinsey · 2016 · data_table
Number of vaccine development programs globally
The Economic Impact of Ford and the F-Series
BCG · 2020 · cover
The Economic Impact of Ford and the F-Series
Context for this document
BCG · 2020 · context
Context for this document
Manufacturing impact / Usage impact
BCG · 2020 · key_messages
Manufacturing impact / Usage impact
Contents of this report
BCG · 2020 · table_of_contents
Contents of this report
Employment impact
BCG · 2020 · section_divider
Employment impact
GDP impact
BCG · 2020 · section_divider
GDP impact
Manufacturing impact
BCG · 2020 · section_divider
Manufacturing impact
Usage impact
BCG · 2020 · transition
Usage impact
Disclaimer
BCG · 2020 · disclaimer
Disclaimer
Ford | BCG
BCG · 2020 · other
Ford | BCG
Building an AI-Fueled Business: Strategy, Platform and Data
IDC · cover
Building an AI-Fueled Business: Strategy, Platform and Data
Super Use cases in Finance - AR - A Functional Example
IDC · process_diagram
Super Use cases in Finance - AR - A Functional Example
Super Use Cases in Manufacturing – An Industry Example
IDC · case_study
Super Use Cases in Manufacturing – An Industry Example
Unified AI Platforms of the Future
IDC · other
Unified AI Platforms of the Future
Unified AI Platform Capabilities
IDC · framework_other
Unified AI Platform Capabilities
AI Ready Data
IDC · section_divider
AI Ready Data
Bosideng Group's Digital Transformation Strategy
IDC · case_study
Bosideng Group's Digital Transformation Strategy
International Data Corporation (IDC)
IDC · disclaimer
International Data Corporation (IDC)
For Additional Information, please contact:
IDC · closing_ask
For Additional Information, please contact:
Goldman Sachs US Financial Services Conference 2022
GoldmanSachs · 2022 · cover
Goldman Sachs US Financial Services Conference 2022
Forward-Looking Statements
GoldmanSachs · 2022 · disclaimer
Forward-Looking Statements
Non-GAAP Information
GoldmanSachs · 2022 · disclaimer
Non-GAAP Information
Investment thesis
GoldmanSachs · 2022 · framework_other
Investment thesis
Low 20s — ROATCE
Where we have been and where we're going
GoldmanSachs · 2022 · context
Where we have been and where we're going
1 Purpose-Driven Culture
GoldmanSachs · 2022 · section_divider
1 Purpose-Driven Culture
Capital allocation philosophy
GoldmanSachs · 2022 · strategic_options
Capital allocation philosophy
TRUIST HH
GoldmanSachs · 2022 · other
TRUIST HH
Appendix
GoldmanSachs · 2022 · appendix
Appendix
Additional notes
GoldmanSachs · 2022 · appendix
Additional notes
Non-GAAP reconciliations
GoldmanSachs · 2022 · appendix
Non-GAAP reconciliations
57.2 — Adjusted Efficiency Ratio
Non-GAAP reconciliations
GoldmanSachs · 2022 · appendix
Non-GAAP reconciliations
0.1% — Adjusted CAGR
Next page →